Two Sigma Investments
BIO icon

Two Sigma Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Two Sigma Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,500
Closed -$4.91M – 2790
2021
Q4 		$4.91M Buy
6,500
+5,500
+550% +$4.12M 0.01% 1206
2021
Q3 		$746K Hold
1,000
– – ﹤0.01% 2892
2021
Q2 		$644K Buy
+1,000
New +$609K ﹤0.01% 2882

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments's BIO Position: Q1 2026 in Review

Two Sigma Investments opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2026: 10,988 shares worth $3.06M. The stake represents ﹤0.01% of the portfolio and ranks #2424 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in BIO as recently as Q4 2024.

Two Sigma Investments first reported a position in BIO in Q2 2013 and has held it in 45 quarters since. The position peaked at $53.6M in Q3 2019. 392 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Two Sigma Investments held 10,988 shares of Bio-Rad Laboratories Class A worth $3.06M as of Q1 2026.
  • Bio-Rad Laboratories Class A was a new Two Sigma Investments position in Q1 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2424 holding.
  • Two Sigma Investments first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 45 quarters since.
  • Two Sigma Investments's Bio-Rad Laboratories Class A position peaked at $53.6M in Q3 2019.
  • 392 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.